We serve Chemical Name:5-Bromo-N-cyclopropyl-3-nitropyridin-2-amine CAS:1010422-24-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Bromo-N-cyclopropyl-3-nitropyridin-2-amine
CAS.NO:1010422-24-8
Synonyms:5-bromo-N-cyclopropyl-3-nitropyridin-2-amine
Molecular Formula:C8H8BrN3O2
Molecular Weight:258.07200
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:70.74000
Exact Mass:256.98000
LogP:2.92280
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-bromo-N-cyclopropyl-3-nitropyridin-2-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-bromo-N-cyclopropyl-3-nitropyridin-2-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromo-N-cyclopropyl-3-nitropyridin-2-amine Use and application,5-bromo-N-cyclopropyl-3-nitropyridin-2-amine technical grade,usp/ep/jp grade.
Related News: At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content. 5-Bromo-N-cyclopropyl-3-nitropyridin-2-amine manufacturer The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented. 5-Bromo-N-cyclopropyl-3-nitropyridin-2-amine supplier Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 5-Bromo-N-cyclopropyl-3-nitropyridin-2-amine vendor Speaking to Sky News, Raab said he could not confirm the ��precise number�� of those arriving into the UK on Sunday. 5-Bromo-N-cyclopropyl-3-nitropyridin-2-amine factory The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.
